• Home
  • Mutual Funds
  • Nippon India Nifty Pharma ETF Growth

Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Fund Overview

Min. investment

SIP ₹0 & Lump. ₹1000

AUM (Fund size)

₹1,248 Cr

Lock In Period

N/A

Expense Ratio

N/A

Benchmark

Nifty Pharma Total Return

Exit Load

Nil

Summary

Latest details for Nippon India Nifty Pharma ETF Growth include a ₹23.0350 NAV as of Apr 22,2026 and returns since inception of 81.36%. Minimum investments start at SIP ₹0. The Nippon India Nifty Pharma ETF Growth AUM is ₹1,248 Cr, with a lock-in of N/A years, expense ratio of N/A%, and benchmark Nifty Pharma Total Return. Exit load is - Nil. In the growth review for 1M Month/Year, the fund recorded -0.47% returns, against a category average of 0.37% and a category best of 19.17%.

Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M-0.470.3719.17
6M0.130.8761.10
1Y5.614.55159.29
3Y21.9513.17224.97

Portfolio Analysis

  • Equity: 99.97%
  • Debt: 0.03%
  • Others
As on: 2026-03-31
View allocation % by

1. Sun Pharmaceutical Industries Limited22.91%
2. Dr. Reddy's Laboratories Limited9.41%
3. Divi's Laboratories Limited9.32%
4. Cipla Limited8.49%
5. Lupin Limited6.91%
6. Torrent Pharmaceuticals Limited5.43%
7. Laurus Labs Limited4.76%
8. Aurobindo Pharma Limited4.49%
9. Glenmark Pharmaceuticals Limited3.96%
10. Alkem Laboratories Limited3.80%
11. Biocon Limited3.17%
12. Mankind Pharma Limited2.80%
13. IPCA Laboratories Limited2.74%
14. Zydus Lifesciences Limited2.69%
15. JB Chemicals & Pharmaceuticals Limited2.09%
16. Gland Pharma Limited1.67%
17. Abbott India Limited1.64%
18. Ajanta Pharma Limited1.46%
19. Wockhardt Limited1.19%
20. Piramal Pharma Limited1.04%

About Fund

Nippon India Nifty Pharma ETF Growth managed by Nippon India Mutual Fund,is a Equity - Index Fundscheme with Assets Under Management of ₹1,248 Crore. The fund benchmarks its performance against the Nifty Pharma Total Return while maintaining an expense ratio of . Under the expert guidance of Jitendra Tolani ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Jitendra Tolani

Mr. Jitendra Tolani holds MBA (FINANCE). Prior to joining Nippon Mutual Fund, he was working with Motilal Oswal Financial Services Ltd, Asit C Mehta Investment Interrmediaries Ltd.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
This FundNippon India ETF Nifty Infrastructure BeES Growth0169.95 CR1.14
This FundMotilal Oswal BSE Financials ex Bank 30 Index Fund Growth026.62 CR1.01
This FundNippon India Nifty Pharma ETF Growth01247.9 CR
This FundKotak Silver ETF Growth03319.12 CR0.35
This FundICICI Prudential Silver ETF Growth014511.43 CR0.4
Fund Name1Y3Y
This FundNippon India ETF Nifty Infrastructure BeES Growth7.051279.7255
This FundMotilal Oswal BSE Financials ex Bank 30 Index Fund Growth6.853280.4703
This FundNippon India Nifty Pharma ETF Growth5.612481.3617
This FundKotak Silver ETF Growth155.5388224.0972
This FundICICI Prudential Silver ETF Growth156.1729224.9749

FAQs

Nippon India Nifty Pharma ETF Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Nippon India Nifty Pharma ETF Growth is . This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Nippon India Nifty Pharma ETF Growth’s fund performance is as follows:
  • 1 Month : -0.47%
  • 6 Months : 0.13%
  • 1 Year : 5.61%
  • 3 Years : 21.95%
Returns of Nippon India Nifty Pharma ETF Growth are updated daily based on NAV of ₹ 23.0350 as on Apr 22,2026. Since inception, the return has been 81.36%.

You can invest in Nippon India Nifty Pharma ETF Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Nippon India Nifty Pharma ETF Growth is ₹1,248 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Nippon India Nifty Pharma ETF Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500